Pneumonia Vaccine Market Set to Surge to $10.21 Billion by 2025 at a 5% CAGR

As of 2017, the global pneumonia vaccine market was valued at approximately $7.08 billion and is projected to reach $10.21 billion by 2025, growing at a CAGR of 5% during the forecast period. The global pneumonia vaccine market has witnessed significant growth in recent years, driven by increasing awareness of preventive healthcare and the rising prevalence of pneumococcal diseases. Pneumonia, an infection that inflames the air sacs in one or both lungs, can be caused by bacteria, viruses, or fungi, with bacterial pneumonia being the most common in adults. Vaccination remains a crucial strategy in combating this disease, leading to a robust market for pneumonia vaccines.

Read More Here: https://www.alliedmarketresearch.com/pneumonia-vaccine-market

Pneumonia Vaccine Market Growth Factors
Several factors contribute to the expansion of the pneumonia vaccine market:
1. Rising Incidence of Pneumonia: The global increase in pneumonia cases, particularly among children under five and the elderly, has led to a higher demand for effective vaccination programs.
2. Government Initiatives: Many governments have implemented immunization programs to reduce the burden of pneumococcal diseases. These initiatives often include funding for vaccine development and distribution, enhancing market growth.
3. Introduction of Novel Vaccines: The development of new pneumococcal vaccines, such as the 20-valent pneumococcal conjugate vaccine, has expanded the options available for immunization, thereby driving market growth.
4. Increased Awareness: Growing public awareness about the benefits of vaccination has led to higher immunization rates, contributing to market expansion.

Get Sample PDF Copy: https://www.alliedmarketresearch.com/request-sample/2730

Pneumonia Vaccine Market Segmentation
The pneumonia vaccine market is segmented based on vaccine type, product type, sector, distribution channel, and region.

1. By Vaccine Type:
◦ Pneumococcal Conjugate Vaccine (PCV): This segment holds a significant share of the market due to its widespread use in immunization programs for children and adults.
◦ Pneumococcal Polysaccharide Vaccine (PPV): Used primarily in adults, this segment is also experiencing growth, particularly with the introduction of new formulations.

2. By Product Type:
◦ Prevnar 13: One of the most widely used vaccines, Prevnar 13 has a substantial market share due to its effectiveness against multiple strains of pneumococcal bacteria.
◦ Synflorix: Another key product in the market, offering protection against various pneumococcal serotypes.
◦ Pneumovax 23: This vaccine covers a broader range of pneumococcal serotypes and is commonly used in adult immunization programs.

3. By Sector:
◦ Public: Government-funded immunization programs contribute significantly to the market, especially in developing countries.
◦ Private: Private healthcare providers also play a crucial role, particularly in developed regions where private healthcare is more prevalent.

4. By Distribution Channel:
◦ Distribution Partner Companies: These entities facilitate the widespread distribution of vaccines, ensuring availability across various regions.
◦ Non-governmental Organizations (NGOs): NGOs often support vaccination programs in underserved areas, contributing to market growth.
◦ Government Authorities: Government agencies are pivotal in the procurement and distribution of vaccines, especially in national immunization programs.

5. By Region:
◦ North America: Holds a significant share of the market due to advanced healthcare infrastructure and high awareness levels.
◦ Europe: Similar to North America, Europe has a substantial market share driven by government initiatives and public awareness.
◦ Asia-Pacific: Expected to witness the fastest growth rate, attributed to increasing government initiatives and rising awareness about pneumonia prevention.
◦ LAMEA (Latin America, Middle East, and Africa): These regions are also experiencing growth, supported by international aid and government programs.

Key Players in the Pneumonia Vaccine Market
The pneumonia vaccine market comprises several key players who contribute to its growth and development. These companies are involved in the research, development, and distribution of pneumonia vaccines globally. Some of the prominent players in the market include:
• GlaxoSmithKline plc
• LG Chem Ltd.
• Merck & Co., Inc.
• Panacea Biotec Limited
• Pfizer Inc.
• Pnuvax Incorporated
• Serum Institute of India Pvt. Ltd.
• Shenzhen Kangtai Biological Products Co., Ltd.
• SK Bioscience
• Walvax Biotechnology Co., Ltd.

These companies are at the forefront of the pneumonia vaccine market, driving innovation and ensuring the availability of vaccines to combat pneumococcal diseases worldwide.

In conclusion, the pneumonia vaccine market continues to expand as healthcare systems worldwide prioritize immunization as a preventive measure. The rising incidence of pneumonia, coupled with continuous advancements in vaccine technology, is expected to drive sustained market growth. With government support and increased public awareness, the industry is well-positioned to combat pneumonia effectively and improve global health outcomes.

Procure Complete Report: https://www.alliedmarketresearch.com/checkout-final/79bcb1d168e64207621a11b3f38fa412

Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.

Contact Us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.